A model to estimate the outcome of prostate cancer photodynamic therapy with TOOKAD Soluble WST11

Author： Betrouni Nacim   Lopes Renaud   Puech Philippe   Colin Pierre   Mordon Serge  

Publisher： IOP Publishing

ISSN： 0031-9155

Source： Physics in Medicine and Biology, Vol.56, Iss.15, 2011-08, pp. : 4771-4783

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11‐vascular‐targeted photodynamic (VTP) therapy

By  

BJU INTERNATIONAL, Vol. 116, Iss. 6, 2015-12 ,pp. : 888-896

John Wiley & Sons Inc

Access to resources Recommend Favorite

Photodynamic Therapy of Prostate Cancer by Means of 5-Aminolevulinic Acid-Induced Protoporphyrin IX – In vivo Experiments on the Dunning Rat Tumor Model

By  

Urologia Internationalis, Vol. 72, Iss. 3, 2004-04 ,pp. : 196-202

Karger

Access to resources Recommend Favorite

Photodynamic Therapy of Head and Neck Cancer

By  

Oncology Research and Treatment, Vol. 24, Iss. 3, 2001-07 ,pp. : 230-237

Karger

Access to resources Recommend Favorite

The Use of Photodynamic Therapy for Skin Cancer

By  

Oncology Research and Treatment, Vol. 21, Iss. 1, 1998-03 ,pp. : 20-27

Karger

Access to resources Recommend Favorite

Outcome of Adjuvant Therapy for Gallbladder Cancer

By  

Oncology, Vol. 79, Iss. 3-4, 2010-12 ,pp. : 168-173

Karger

Access to resources Recommend Favorite